Ironwood Pharmaceuticals Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$133,040	$113,041	$106,506	$47,709
Gross Profit	133,040	113,041	106,063	47,709
EBITDA	93,794	81,391	74,756	8,801
EBIT	93,794	80,934	74,313	8,341
Net Income	59,838	51,291	40,773	-2,276
Net Change In Cash	133,040	113,041	106,506	47,709
Free Cash Flow	67,401	58,276	5,121	74,576
Cash	86,376	79,127	220,471	215,456
Basic Shares	166,000	165,454	166,690	177,764

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$296,151	$351,410	$442,735	$410,596
Gross Profit	296,151	343,858	436,587	409,178
EBITDA	104,652	97,728	197,411	261,438
EBIT	102,771	95,717	195,836	260,020
Net Income	24,017	880	-1,002,239	175,065
Net Change In Cash	296,151	351,410	442,735	410,596
Cost of Revenue				36,074
Free Cash Flow	127,010	103,407	183,154	273,627
Cash	215,456	88,559	92,154	656,203
Basic Shares	177,764	160,084	155,435	186,312